Lithium Directs Embryonic Stem Cell Differentiation Into Hemangioblast-Like Cells

Area of Science:

• Developmental biology
• Stem cell research
• Hematopoiesis

Background:

• Definitive hematopoietic stem cells (HSCs) originate from the hemogenic endothelium (HE) during embryonic development.
• Pluripotent stem cells (PSCs) offer a potential source for in vitro HSC generation.
• Wnt/β-catenin signaling is critical for PSC-derived HSC formation.

Purpose of the Study:

• To investigate lithium's role in inducing ESC differentiation towards HSC precursors.
• To establish a novel in vitro strategy for generating HSCs from PSCs.

Main Methods:

• Embryonic stem cells (ESCs) were treated with lithium (a GSK3 inhibitor) to stabilize β-catenin.
• Flow cytometry was used to analyze cell surface markers (CD31, SCA-1, Nkx2-5, CD34, FLK1).
• Maturation medium was used to induce further differentiation into hemogenic endothelium (HE) markers (RUNX1, SOX17).

Main Results:

• Lithium treatment induced ESCs to differentiate into hemangioblast-like cells expressing specific markers.
• These cells were arrested in a hemangioblast-like phase until exposed to maturation medium.
• Maturation led to a significant increase in cells expressing HE markers RUNX1 and SOX17.

Conclusions:

• Lithium effectively promotes ESC differentiation into HSC precursors via hemangioblast and HE stages.
• This provides a novel and efficient in vitro method for generating HSC precursors.
• This strategy holds promise for developing new therapies for blood-related diseases.